GeoVax Awarded $658,000 NIH Grant for its HIV Vaccine Program
ATLANTA, GA – (NewMediaWire) – April 03, 2017 – GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines, announced today it ha
GeoVax Awarded 8,000 NIH Grant for its HIV Vaccine Program
Source: Virology News